Comparing RNA expression (transcripts per million, tpm), and not estimated protein activity, across the cohort, BCL-XL again ranked highest among the antiapoptotic BCL-2 proteins investigated in CRC. This evidence concerns the gene BCL2L1 and colorectal carcinoma.